Enalapril Maleate Oral Solution

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of enalapril maleate oral solution in China. Welcome to wholesale bulk high quality enalapril maleate oral solution for sale here from our factory. Good service and reasonable price are available.

Enalapril Maleate Oral Solution is an oral preparation containing Enalapril Maleate as the active ingredient. Enalapril maleate is the maleic acid salt form of Enalapril, chemically described as (S) -1- [N - [1- (ethoxycarbonyl) -3-phenylpropyl] - L-alanyl] - L-proline, (Z) -2-butenedioic acid salt (1:1), with the molecular formula C20H28N2O5 • C4H4O4. It is usually a colorless and transparent liquid with a mixed berry flavor, which is easy for patients to accept.

Each 1 milliliter of the preparation contains 1 milligrams of enalapril maleate (equivalent to 0.764 milligrams of enalapril). In addition to active ingredients, it also contains a variety of auxiliary materials, such as citric acid, mixed berry essence, purified water, sodium citrate, methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, xylitol and sucralose, which are used to adjust the pH value, taste and stability of the solution. This oral solution is typically packaged in a 150ml brown glass bottle, equipped with a 10ml syringe and bottle adapter for precise dosing. This packaging design ensures the photostability of the drug and facilitates patient use.

Enalapril Maleate COA

Evolution of Taste Masking Technology: From "Whitening Peace" to "Molecular Imprisonment"

 

Enalapril Maleate Oral Solution, as a classic angiotensin-converting enzyme inhibitor (ACEI), has been a core drug for the treatment of hypertension, heart failure, and asymptomatic left ventricular dysfunction since its FDA approval in 1985. However, its strong bitterness leads to a significant decrease in patient compliance, especially among children, the elderly, and patients with swallowing difficulties.

 

According to statistics, over 50% of pediatric patients refuse to take medication due to poor taste, which directly leads to treatment interruption and disease deterioration. To solve this problem, taste masking technology has evolved from simple taste correction to molecular level precise control, ultimately achieving a leap from "whitewashing" to "molecular confinement".

Traditional flavor correction technique: surface modification of "smoothing out peace"

Combination application of sweeteners and aromatic agents

Early taste masking technology takes sweeteners (such as sucrose, saccharin sodium, aspartame) and aromatics (such as mixed berry essence, lemon essence) as the core to mask bitterness through the neural integration interference of taste signals. For example, Epaned oral solution is added with sorbitol, sucralose and mixed berry essence to form multi-level taste stimulation. However, such methods have limited effectiveness on high solubility and strong bitterness drugs.

Research has shown that when the drug concentration exceeds the taste threshold (such as the critical concentration of enalapril in saliva being 0.1mg/mL), sweeteners are unable to completely suppress bitterness perception.

Limitations of pH Adjustment and Salting Technology

In response to the pH dependent solubility characteristics of enalapril, researchers attempted to reduce drug solubility by adjusting the solution pH (such as adding a citric acid/sodium citrate buffer system).

For example, controlling the pH within the range of 4.0-5.0 can reduce the solubility of enalapril by 30% -40%.

However, such methods require a balance between bioavailability and taste masking effect: low pH may cause gastrointestinal irritation, while high pH can affect drug stability. In addition, although salt formation techniques (such as forming enalapril saccharin salt with sodium saccharin) can reduce bitterness, they may alter the drug crystal form and affect dissolution rate.

Core Defects of Traditional Technologies

Traditional flavor correction techniques are essentially "surface modifications" that do not alter the direct contact between drug molecules and taste buds. Its limitations are reflected in:Dose dependence: High dose drugs are prone to breaking through the masking threshold of sweeteners;Individual differences: Taste sensitivity is influenced by age and genetic factors, with children's perception threshold for bitterness being 2-3 times lower than adults;Accessory safety: Excessive use of sweeteners may cause metabolic disorders, while natural sweeteners may cause diarrhea.

Physical barrier technology: building a taste "firewall" 

 

Microencapsulation Technology

A Breakthrough from Laboratory to Industrialization-Microencapsulation involves encapsulating drug molecules in micrometer sized particles through polymer coating, forming a physical barrier. The research adopts spray drying method, and Eudragit EPO ® Prepare Enalapril Maleate Oral Solution microparticles as coating material. The experiment shows that:process optimization: Under the conditions of inlet temperature of 65 ℃, outlet temperature of 30 ℃, and pump speed of 10%, the particle yield reaches 51.3% -85.4%, and the drug loading is 7.75% -24.69%;

Taste masking effect: The drug release in artificial saliva is less than 5%, and animal experiments have shown a significant reduction in bitterness perception;Bioavailability: Compared with regular tablets, the Cmax and AUC of particulate formulations have bioequivalence of 90% -115%.

Industrial application of coating technology
Coating technology forms a continuous film layer on the surface of drug particles, blocking the contact between drugs and taste buds. For example, after coating compound Chuanxinlian granules with Eudragit E100, the bitterness score decreased from 4.2 points (original) to 1.8 points (after coating).

However, coating technology faces challenges:Membrane integrity: Enzymatic hydrolysis in saliva may cause coating rupture;Process complexity: Multi layer coating requires precise control of temperature, humidity, and spraying rate;Auxiliary material cost: The Eudragit series polymer has a higher price, which increases production costs.

Core breakthroughs in physical barrier technology

Physical barrier technology achieves physical isolation between drug molecules and taste buds by constructing a "taste firewall". Its advantages lie in:

Universality: Suitable for water-soluble and poorly soluble drugs.

Molecular level odor masking technology: from "passive isolation" to "active confinement"

Ion exchange resin: precise control of charge interactions

Ion exchange resin immobilizes drug molecules in the resin pores through electrostatic interactions, blocking their release. The study used Amberlite IRP-69 resin to form a composite after loading enalapril. The experiment shows that:Load capacity: Each gram of resin can load 120-150mg of enalapril;
Taste masking mechanism: In saliva (pH 6.8), the drug release is less than 10%, while in gastric juice (pH 1.2), 90% of the drug is released within 30 minutes;Bioavailability: Compared with regular tablets, the Tmax of resin composites is extended by 1 hour, but there is no significant difference in AUC.

Cyclodextrin Inclusion: The "Molecular Cage" of Spatial Structure

Cyclodextrin encapsulates drug molecules through hydrophobic cavities to form supramolecular complexes. The study used β - cyclodextrin to encapsulate enalapril, forming a 1:1 inclusion complex. The experiment shows that:Encapsulation efficiency: The encapsulation constant reaches 10 ^ 4 L/mol, and the encapsulation rate is greater than 90%;Taste masking effect: When the drug release in artificial saliva is less than 5%, the bitterness perception threshold is increased by 4 times;Stability: The degradation of the inclusion complex is less than 5% within 6 months in an accelerated test at 40 ℃.

Precursor technology: chemically modified "bitterness digestion"

Prodrug technology changes the molecular structure of drugs through chemical modifications, reducing their binding ability to taste buds receptors. The research design of enalapril prodrug showed that:Taste improvement: The bitterness score of the prodrug has decreased from 4.5 points of the original drug to 1.2 points;Biotransformation: Under the action of esterase in the body, the prodrug is completely converted to enalapril within 30 minutes.

Core advantages of molecular level technology

Molecular level masking technology achieves a leap from "passive isolation" to "active confinement" by actively controlling the behavior of drug molecules. Its advantages lie in:Precision: precise control of drug release through intermolecular forces such as electrostatic, hydrophobic, and covalent bonds;
Long term effect: The masking effect is not affected by saliva secretion;
Biocompatibility: All materials used (such as cyclodextrin and ion exchange resin) have passed FDA certification and have high safety.

The clinical value of technological evolution: from "treatment compliance" to "health management"

Revolutionary breakthrough in pediatric medication

The approval of Epaned oral solution marks a new stage in the treatment of pediatric hypertension. Clinical studies have shown that:

Compliance improvement: The interruption rate of treatment for patients using oral solutions has decreased from 32% to 8%.

Blood pressure control:

After 12 weeks of treatment, systolic blood pressure decreased by 12-15mmHg, and the compliance rate increased by 25%;

Safety:

There was no significant difference in the incidence of adverse reactions between tablets and tablets (p>0.05).

 

Long term benefits of chronic disease management

The advancement of taste masking technology not only improves single dose adherence, but also promotes long-term management of chronic diseases. For example:

Heart failure patients: The masking solution reduces the daily medication intake from 2 times to 1 time, resulting in an 18% decrease in hospitalization rate;

Medication optimization for elderly patients

Elderly patients are more sensitive to the taste of medication due to difficulty swallowing and taste degradation. Research shows that:

Swallowing convenience: The success rate of swallowing oral solutions is 40% higher than that of tablets;Taste acceptance: 85% of elderly patients consider the taste of the solution to be "acceptable" or "good";Drug interaction: When the solution formulation is taken with food, Cmax decreases by 20%, but AUC does not show significant changes, indicating that the administration time can be flexibly adjusted.

Future Outlook: From "Single Technology" to "Intelligent Systems"

Personalized customization of 3D printing technology

3D printing technology can achieve personalized customization of drug dosage forms, doses, and release curves. For example, by printing multiple layers of structures, the outer layer is a masking layer (containing sweeteners and coating materials), and the inner layer is the drug core, achieving a two-stage release of "immediate release sustained release".

Precise delivery of nanotechnology

 

Nanocarriers, such as liposomes and polymer nanoparticles, can encapsulate drug molecules and achieve targeted delivery through mucosal adsorption. Research has shown that the retention time of Enalapril Maleate Oral Solution nanoparticles in oral mucosa is three times longer and bitterness perception is reduced by 80%.

Taste prediction using artificial intelligence

 

The taste prediction model based on machine learning can screen the optimal taste masking scheme. For example, by analyzing the molecular structure of drugs, properties of excipients, and process parameters, predicting the masking effect, the research and development cycle can be shortened from 18 months to 6 months.

FAQ

What is enalapril maleate used for?

Hot Tags: enalapril maleate oral solution, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale